| |
|
|
|
Oramed Pharma  
|
|
2.79 -0.03 (-0.01%) |
10-20 16:00 |
|
Open: |
2.87 |
Pre close: |
2.82 |
Target:
|
3.67 
|
|
High: |
2.87 |
Low: |
2.75 |
Resistance:
|
3.14
3.67
|
|
Volume: |
76,049 |
Market Cap: |
66M |
Support:
|
2.68
2.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.68
|
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
2.67  |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
3.42 |
Stochastic Oscillator |
%K(14,3):
|
68.90 |
|
MA(250): |
3.72 |
%D(3): |
52.80 |
|
Average Volume(K) |
3-Month: |
13841
|
52-Week |
High:
|
6.05 |
|
10-Days: |
11988 |
Low: |
2.32 |
|
RSI |
RSI(14):
|
51.60 |
Change(%): |
-11.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.569 |
Return on Equity (ttm) |
-38.8 |
Shares Out. (M) |
23.53 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-16.6 |
Shares Float (M) |
20.65 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.06 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
-0.1 |
% Held by Institutions |
12.18 |
|
Forward EPS |
0.820 |
Gross Profit (p.s.) |
0.111 |
Shares Short (K) |
193 |
|
Book Value (p.s.) |
1.470 |
EBITDA (p.s.) |
-0.471 |
P/E |
-4.97 |
|
Sales Per Share |
0.115 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.93 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.25 |
P/S |
24.57 |
|
Operating Margin |
-409.04 |
Levered Free Cash Flow
(M) |
-7.08 |
P/CF |
-5.03 |
|
|
|
|
|
|
